Radiation therapy for aggressive fibromatosis (desmoid tumor) [10]

Journal of Clinical Oncology

Volumn 24, Issue 22, 2006, Pages 3714-3715

  Ray, Michael E ^a   Lawrence, Theodore S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IMATINIB; METHOTREXATE; VINBLASTINE; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; DESMOID TUMOR; FIBROMATOSIS; HUMAN; LETTER; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; NOTE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FIBROMATOSIS, AGGRESSIVE; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT;

EID: 33747068273     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.7306     Document Type: Letter

References (5)

1. Heinrich MC, McArthur GA, Demetri GD, et al: Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 24:1195-1203, 2006
2. Ballo MT, Zagars GK, Pollack A, et al: Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 17:158-167, 1999
3. Nuyttens JJ, Rust PF, Thomas CR Jr, et al: Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer 88:1517-1523, 2000
4. Micke O, Seegenschmiedt MH: Radiation therapy for aggressive fibromatosis (desmoid tumors): Results of a national Patterns of Care Study. Int J Radiat Oncol Biol Phys 61:882-891, 2005
5. Ballo MT, Zagars GK, Pollack A: Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 42:1007-1014, 1998